Understand the Administration of Medication to Individuals with Dementia — OCN London Apprenticeship Assessment Qualification Health & Social Care Revision
This element focuses on the pharmacological interventions commonly prescribed for dementia, including acetylcholinesterase inhibitors and NMDA receptor ant
Topic Synopsis
This element focuses on the pharmacological interventions commonly prescribed for dementia, including acetylcholinesterase inhibitors and NMDA receptor antagonists, and their appropriate use in managing cognitive symptoms. It also emphasises the integration of medication administration within a person-centred framework, ensuring that treatment choices and delivery respect the individual's preferences, capacity, and holistic needs while maintaining safety and efficacy.
Key Concepts & Core Principles
- Person-centred care: Tailoring support to the individual's preferences, history, and needs, recognising them as a unique person beyond their diagnosis.
- Types of dementia: Understanding Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, including their distinct symptoms and progression.
- Communication strategies: Using verbal and non-verbal techniques, such as active listening, simple language, and validation therapy, to reduce confusion and distress.
- Legal frameworks: Applying the Mental Capacity Act 2005, Deprivation of Liberty Safeguards, and the Equality Act 2010 to protect rights and ensure ethical care.
- Risk factors and prevention: Identifying modifiable risks like hypertension, smoking, and social isolation, and promoting brain-healthy lifestyles.
Exam Tips & Revision Strategies
- Always anchor your responses in person-centred care: mention specific strategies like using simple language, checking understanding, and respecting refusals while documenting capacity assessments.
- Use concrete examples of medication types and their side effect profiles (e.g., gastrointestinal issues with donepezil, dizziness with memantine) to demonstrate applied knowledge.
- Reference relevant legislation and ethical frameworks (e.g., Mental Capacity Act 2005, Deprivation of Liberty Safeguards) when discussing covert administration or best-interest decisions.
- In assessment tasks, clearly separate pharmacological interventions from non-pharmacological approaches, and explain how you would evaluate the effectiveness of medication within a holistic care plan.
Common Misconceptions & Mistakes to Avoid
- Confusing dementia-specific medications with antipsychotics used for behavioural and psychological symptoms, leading to inappropriate application of treatment goals.
- Assuming that medication alone can stop or reverse dementia progression, rather than viewing it as part of a broader, person-centred care plan that includes non-pharmacological strategies.
- Neglecting the principles of consent and mental capacity, for example, administering medication covertly without proper legal and ethical justification or documentation.
- Overlooking the impact of polypharmacy and anticholinergic burden on older adults with dementia, which can worsen cognitive decline and increase side effect risks.
Examiner Marking Points
- Award credit for demonstrating accurate knowledge of at least two common medication types (e.g., donepezil, rivastigmine, galantamine, or memantine) and their intended therapeutic effects.
- Award credit for explaining how to apply person-centred principles during medication administration, such as obtaining consent, adapting communication for cognitive impairment, and involving the individual in decision-making.
- Award credit for outlining the importance of monitoring for side effects and adverse reactions, and describing the correct procedures for recording and reporting concerns to a healthcare professional.
- Award credit for recognising that medications are not curative and must be used alongside psychosocial interventions, with evidence of understanding the risks of over-reliance on pharmacological approaches.